Cleared Traditional

ELLAVI UBT

K230849 · Sinapi Biomedical (Pty) , Ltd. · Obstetrics & Gynecology
Nov 2023
Decision
230d
Days
Class 2
Risk

About This 510(k) Submission

K230849 is an FDA 510(k) clearance for the ELLAVI UBT, a Intrauterine Tamponade Balloon (Class II — Special Controls, product code OQY), submitted by Sinapi Biomedical (Pty) , Ltd. (Stellenbosch, ZA). The FDA issued a Cleared decision on November 13, 2023, 230 days after receiving the submission on March 28, 2023. This device falls under the Obstetrics & Gynecology review panel. Regulated under 21 CFR 884.4530.

Submission Details

510(k) Number K230849 FDA.gov
FDA Decision Cleared SESE
Date Received March 28, 2023
Decision Date November 13, 2023
Days to Decision 230 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code OQY — Intrauterine Tamponade Balloon
Device Class Class II — Special Controls
CFR Regulation 21 CFR 884.4530
Definition Provides Temporary Control Or Reduction Of Postpartum Uterine Bleeding

Similar Devices — OQY Intrauterine Tamponade Balloon

All 9
Bakri Essential Postpartum Balloon
K223098 · Cook Incorporated · Oct 2022
Jada System
K212757 · Alydia Health · Sep 2021
Jada System
K201199 · Alydia Health · Aug 2020
Every Second Matters-Uterine Balloon Tamponade (?ESM-UBT?)
K191264 · Ujenzi Charitable Trust · Oct 2019
Bakri Postpartum Balloon, Bakri Postpartum Balloon with Rapid Instillation Component
K170622 · Cook Incorporated · Mar 2017
ebb Complete Tamponade System
K153591 · Clinical Innovations, LLC · Jan 2016